Dasatinib inhibits TGFβ-induced myofibroblast differentiation through Src-SRF Pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dasatinib inhibits TGFβ-induced myofibroblast differentiation through Src-SRF Pathway

Published:2015-12 Issue: Volume:769 Page:134-142
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Abdalla Maha,Thompson LeeAnn,Gurley Erin,Burke Samantha,Ujjin Jessica,Newsome Robert,Somanath Payaningal R.

Funder

National Institutes of Health

University of Georgia Research Foundation

Wilson Pharmacy Foundation to PRS

American Heart Association

Publisher

Elsevier BV

Subject

Pharmacology

Reference36 articles.

1. Akt1 mediates alpha-smooth muscle actin expression and myofibroblast differentiation via myocardin and serum response factor;Abdalla;J. Biol. Chem.,2013

2. Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice;Aono;Am. J. Respir. Crit. Care Med.,2005

3. Transforming growth factor beta down-regulates Src family protein tyrosine kinase signaling pathways;Atfi;J. Biol. Chem.,1994

4. Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results;Daniels;Am. J. Respir. Crit. Care Med.,2010

5. Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis;Daniels;J. Clin. Investig.,2004

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spatially resolved metabolomics visualizes heterogeneous distribution of metabolites in lung tissue and the anti-pulmonary fibrosis effect of Prismatomeris connate extract;Journal of Pharmaceutical Analysis;2024-03

2. Therapeutic Potential of Benzimidazoisoquinoline Derivatives in Alleviating Murine Hepatic Fibrosis;Chemistry & Biodiversity;2024-01-25

3. Emerging opportunities to treat idiopathic pulmonary fibrosis: Design, discovery, and optimizations of small-molecule drugs targeting fibrogenic pathways;European Journal of Medicinal Chemistry;2023-11

4. A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis;Clinical Cancer Research;2023-07-13

5. Generation and characterization of two immortalized dermal fibroblast cell lines from the spiny mouse (Acomys);PLOS ONE;2023-07-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3